Table 4.
Independent predictors of death in the patients receiving echinocandin as antifungal therapy with respect to local guidelines, according to 3 different Cox analysis models
| Hazard ratio | 95% CI | p | |
|---|---|---|---|
| Duration of echinocandin therapy |
0.88 |
0.78–0.99 |
0.05 |
| RRT on D1 |
3.05 |
1.29–7.19 |
0.01 |
| |
Hazard ratio |
95% CI |
p
|
| Empiric therapy (Yes) |
1.50 |
0.57–3.96 |
0.41 |
| RRT on D1 |
3.05 |
1.29–7.19 |
0.01 |
| |
Hazard ratio |
95% CI |
p
|
| Duration of echinocandin therapy |
0.91 |
0.81–1.01 |
0.07 |
| Empiric therapy (Yes) |
1.19 |
0.43–3.25 |
0.74 |
| RRT on D1 | 3.20 | 1.29–8.00 | 0.01 |
D: day; SOFA: sequential organ failure assessment; RRT: renal replacement therapy; CI: confidence interval.